INR Goal for Mechanical Aortic Valve Replacement
For patients with a mechanical aortic valve replacement without additional risk factors, the recommended INR target is 2.5 (range 2.0-3.0). 1
For patients with a mechanical aortic valve and additional risk factors for thromboembolism, the target INR should be increased to 3.0 (range 2.5-3.5).
Detailed Recommendations Based on Valve Type and Risk Factors
Standard Mechanical Aortic Valve (Bileaflet or Current-Generation Single Tilting Disc)
Without risk factors:
With additional risk factors:
Older-Generation Mechanical Aortic Valve (Ball-in-Cage)
- Target INR: 3.0 (range 2.5-3.5) 1, 2
- These valves have higher thrombogenicity requiring more intense anticoagulation
Special Considerations
On-X Mechanical Aortic Valve
- For On-X valves specifically, a lower INR of 1.5-2.0 plus aspirin (75-100 mg daily) may be reasonable starting 3 months after surgery 3, 4
- This is based on newer evidence showing reduced bleeding complications without increased thrombotic events
Adjunctive Therapy
- Aspirin 75-100 mg daily is recommended in addition to warfarin for all patients with mechanical valve prostheses 1, 2
- This combination significantly reduces the risk of thromboembolism and mortality compared to warfarin alone
Important Caveats and Pitfalls
Avoid excessive anticoagulation: INR values >4.0 provide no additional therapeutic benefit and significantly increase bleeding risk 2
Monitoring frequency: Regular INR monitoring is crucial for maintaining therapeutic range. Patients with a target INR of 2.0-3.5 typically stay in range 74.5% of the time, while those with higher targets (3.0-4.5) are in range only 44.5% of the time 1, 3
Direct oral anticoagulants (DOACs): These are contraindicated for mechanical valves and should never be used as a substitute for warfarin 3
Bridging anticoagulation: When INR falls below therapeutic range, bridging with heparin may be necessary, particularly for higher-risk patients 1
Recent evidence challenging higher INR targets: Some recent research suggests that standard-intensity anticoagulation (INR 2.5) may be associated with fewer bleeding events than higher-intensity anticoagulation (INR 3.0) in patients with mechanical AVR and additional risk factors, without increasing thromboembolic events 5. However, current guidelines still recommend the higher target for these patients.